Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Clemence Verdier

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clemence Verdier, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant <i>Escherichia coli</i>, In Vitro and in a Murine Peritonitis ModelSamuel Chosidow, Bruno Fantin, Irène Nicolas, et al.
The Pediatric Infectious Disease Journal|July 18, 2023
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series AnalysisArnaud Callies, Lise Martin-Perceval, Lise Crémet, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clemence Verdier, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant <i>Escherichia coli</i>, In Vitro and in a Murine Peritonitis ModelSamuel Chosidow, Bruno Fantin, Irène Nicolas, et al.
The Pediatric Infectious Disease Journal|July 18, 2023
Safety and Efficacy of Ceftaroline in Neonates With Staphylococcal Late-onset Sepsis: A Case Series AnalysisArnaud Callies, Lise Martin-Perceval, Lise Crémet, et al.
Pageof 1